Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $15.18 billion. The enterprise value is $25.68 billion.
| Market Cap | 15.18B |
| Enterprise Value | 25.68B |
Important Dates
The last earnings date was Tuesday, July 22, 2025, before market open.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 88.35 million shares outstanding. The number of shares has decreased by -6.96% in one year.
| Current Share Class | 88.35M |
| Shares Outstanding | 88.35M |
| Shares Change (YoY) | -6.96% |
| Shares Change (QoQ) | -3.40% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 106.53% |
| Float | 87.62M |
Valuation Ratios
The trailing PE ratio is 10.98 and the forward PE ratio is 11.14. THC's PEG ratio is 0.69.
| PE Ratio | 10.98 |
| Forward PE | 11.14 |
| PS Ratio | 0.78 |
| Forward PS | 0.70 |
| PB Ratio | 4.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.74 |
| P/OCF Ratio | 6.14 |
| PEG Ratio | 0.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.93, with an EV/FCF ratio of 16.53.
| EV / Earnings | 17.30 |
| EV / Sales | 1.24 |
| EV / EBITDA | 5.93 |
| EV / EBIT | 7.30 |
| EV / FCF | 16.53 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.59.
| Current Ratio | 1.71 |
| Quick Ratio | 1.48 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 2.77 |
| Debt / FCF | 8.48 |
| Interest Coverage | 4.32 |
Financial Efficiency
Return on equity (ROE) is 29.65% and return on invested capital (ROIC) is 10.41%.
| Return on Equity (ROE) | 29.65% |
| Return on Assets (ROA) | 7.58% |
| Return on Invested Capital (ROIC) | 10.41% |
| Return on Capital Employed (ROCE) | 14.40% |
| Revenue Per Employee | $211,051 |
| Profits Per Employee | $15,143 |
| Employee Count | 98,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 34.03 |
Taxes
In the past 12 months, THC has paid $587.00 million in taxes.
| Income Tax | 587.00M |
| Effective Tax Rate | 19.67% |
Stock Price Statistics
The stock price has increased by +13.46% in the last 52 weeks. The beta is 1.52, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +13.46% |
| 50-Day Moving Average | 167.23 |
| 200-Day Moving Average | 146.15 |
| Relative Strength Index (RSI) | 59.76 |
| Average Volume (20 Days) | 1,673,891 |
Short Selling Information
The latest short interest is 3.09 million, so 3.50% of the outstanding shares have been sold short.
| Short Interest | 3.09M |
| Short Previous Month | 3.50M |
| Short % of Shares Out | 3.50% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, THC had revenue of $20.68 billion and earned $1.48 billion in profits. Earnings per share was $15.65.
| Revenue | 20.68B |
| Gross Profit | 8.43B |
| Operating Income | 3.52B |
| Pretax Income | 3.76B |
| Net Income | 1.48B |
| EBITDA | 4.33B |
| EBIT | 3.52B |
| Earnings Per Share (EPS) | $15.65 |
Balance Sheet
The company has $2.63 billion in cash and $13.18 billion in debt, giving a net cash position of -$10.55 billion or -$119.41 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 13.18B |
| Net Cash | -10.55B |
| Net Cash Per Share | -$119.41 |
| Equity (Book Value) | 8.30B |
| Book Value Per Share | 42.44 |
| Working Capital | 3.03B |
Cash Flow
In the last 12 months, operating cash flow was $2.47 billion and capital expenditures -$912.00 million, giving a free cash flow of $1.55 billion.
| Operating Cash Flow | 2.47B |
| Capital Expenditures | -912.00M |
| Free Cash Flow | 1.55B |
| FCF Per Share | $17.58 |
Margins
Gross margin is 40.78%, with operating and profit margins of 17.00% and 7.17%.
| Gross Margin | 40.78% |
| Operating Margin | 17.00% |
| Pretax Margin | 14.43% |
| Profit Margin | 7.17% |
| EBITDA Margin | 20.95% |
| EBIT Margin | 17.00% |
| FCF Margin | 7.51% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.96% |
| Shareholder Yield | 6.96% |
| Earnings Yield | 9.81% |
| FCF Yield | 10.27% |
Analyst Forecast
The average price target for THC is $193.13, which is 12.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $193.13 |
| Price Target Difference | 12.37% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 3.36% |
| EPS Growth Forecast (5Y) | -7.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.84 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 6 |